https://www.selleckchem.com/pr....oducts/dabrafenib-gs
The heritability of these three tumor types was consistently strong and significant with 64% (s.e.m.=0.13; P0.001) for pituitary tumor, 65% (s.e.m.=0.21; P0.001) for adrenal tumors, and 97% (s.e.m.=0.41; P=0.006) for thNETs. The present study shows the existence of modifying genetic factors for thymus, adrenal, and pituitary MEN1 tumor types. The identification of at-risk subgroups of individuals within cohorts is the first step toward personalization of care. Next generation sequencing on this subset of tumors wil
Like
Comment
Share
